News Amazon is absolutely serious about disrupting healthcare After months of speculation around how Amazon will enter the healthcare market, the home deli
News Nektar, BioMarin, and Alnylam top list of biotech M&A target... With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are th
News Takeda to cut IT, marketing and sales jobs after Shire merge... Takeda aiming for $1.4bn savings per year
News Takeda takes biggest gamble of 2018 with Shire merger Takeda and Shire have agreed on the remaining terms of their £46 billion merger, creating one of the largest pharma companies in the world.
Views & Analysis Digital health round-up: Nokia sells digital health unit bac... Saga of Nokia's ill-fated digital health venture comes to a close
News FDA probing cancer cases with Bluebird's CALD gene therapy The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
